Siemens partners with Case Western on MR ‘fingerprinting’ project

Siemens healthcare has partnered with Case Western Reserve University to advance the development of magnetic resonance fingerprinting (MRF), an innovative imaging method capable of analyzing tissues to speed diagnosis of certain diseases.

The technique involves collecting tissue information from signal evolutions, which act as unique ‘fingerprints’ of specific tissue properties. These signals are then compared to a database containing identification features of the associated tissues, including T1, T2, relative spin density and diffusion. 

The partnership has already resulted in successful MRF testing on brain and prostate tumor patients, with future studies expected to expand on the technology and cover additional applications. 

Read the full announcement.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.